fda glp-1 compounding crackdown october 2025 Compounded GLP-1s Become Illegal, Price Cuts Roll Out September 15, 2025: Telehealth company

For some individuals, this can be a challenge when starting or increasing treatment, which is why gradual dose increases and ongoing support are important

however, this approach may introduce immortal time bias

Sensitivity analyses were performed to assess the impact of the definition of MACE (three-point MACE [non-fatal myocardial infarction, non-fatal stroke and cardiovascular death] vs other MACE definitions), risk of bias, data source (electronic healthcare records vs other data sources) and method of adjusting for confounding (propensity scores or inverse probability of treatment weighting vs multivariable regression, restriction or matching)

The company now faces multiple class action lawsuits

Reduced tolerance is widely reported